Skip to content
Certified ManufacturersFor manufacturers
Back to profile

Canadian Phytopharmaceuticals Corporation: due-diligence report

Public-record summary and buyer worksheet. Records can be incomplete; a listing is not product approval, an audit result or a guarantee of suitability. This report updates as source records change. Print a dated copy to retain the version you reviewed.

Share this report: https://certifiedmanufacturers.com/manufacturers/canadian-phytopharmaceuticals/due-diligence

Profile last verified: Oct 26, 2026. Report printed / reviewed on: ____________________

Certifications and licences

Health Canada natural health product site licence (GMP)

Issuer: Health Canada. Registry status: active. Checked: Oct 26, 2026.

Reference: 300094. Expiry: Not recorded.

Scope: Not recorded here; confirm with the registry and manufacturer.

Registry source: https://www.drug-inspections.canada.ca/nhp/inspectionDetail-en.html?lang=en&insNumber=84802

Facilities

Canadian Phytopharmaceuticals Corporation, 12233 Riverside Way, Richmond, BC, V6W 1K8, CA — manufacturing; source: Health Canada; checked Oct 26, 2026.

FDA inspection history

Dataset date: Oct 22, 2026. Facility records are matched by company and location; confirm that the site is the one in your quote. FDA inspection source.

Mar 8, 2013 — NAI: No action indicated

Canadian Phytopharmaceuticals, Richmond, Canada. FEI: 3005452106; inspection: 826462.

Food Composition, Standards, Labeling and Econ

FDA recalls

Dataset date: Oct 27, 2026. Recall matches use company names and may concern a different product or facility.

No matched recall events in the imported dataset. This is not proof of a recall-free history.

Company website claims — not registry verified

Last website check: Oct 16, 2026.

“Large-scale herbal extraction and vacuum evaporation are used to transform raw plant materials into standardized liquid or powdered extracts.”

Last seen Oct 16, 2026. https://www.canphyto.com/facilities-capabilities

“Softgels for oil-based and lipid-soluble ingredients — omega-3s, fish oils, fat-soluble vitamins, and botanical oils”

Last seen Oct 16, 2026. https://www.canphyto.com/formats-packaging

“Manufacture existing products as-is or develop custom formulations aligned with brand, market, and regulatory goals.”

Last seen Oct 16, 2026. https://www.canphyto.com/services

“End-to-end product development and manufacturing managed through a single, integrated workflow.”

Last seen Oct 16, 2026. https://www.canphyto.com/idea-to-shelf-manufacturing

“Single-serve powder packaging is one of the fastest-growing formats in the natural health product market — and CPC produces it fully in-house.”

Last seen Oct 16, 2026. https://www.canphyto.com/formats-packaging

Evidence to request from the manufacturer

Public records cannot answer these questions. Mark each item after reviewing the evidence. Blank means not assessed, not a failed audit. Notes entered here are not saved or included in a shared URL.

Request role-specific training records and the named quality contact.

21 CFR 111.12

Request a site walkthrough, sanitation controls and equipment maintenance records (also §111.25).

21 CFR 111.20

Request written identity, purity, strength, composition and contaminant specifications for your product.

21 CFR 111.70

Ask how each dietary ingredient is identified and how suppliers and certificates of analysis are qualified.

21 CFR 111.75

Request quality control procedures, release authority and handling of deviations and rejected batches.

21 CFR 111.105

Request the approved product-specific master manufacturing record and change-control process.

21 CFR 111.205

Review a completed batch record with traceability to components, processing and release.

21 CFR 111.255

Request scientifically valid test methods, sampling plans and laboratory controls for your specifications.

21 CFR 111.315

Request procedures that prevent label mix-ups and control packaging and label reconciliation.

21 CFR 111.403

Ask how storage conditions protect identity, purity, strength and composition during holding and distribution.

21 CFR 111.453

Request complaint review and investigation procedures; discuss returned-product controls under §111.503.

21 CFR 111.553

Confirm retention and access to records supporting your batches.

21 CFR 111.605